Dr. Adam Czynski, DO, is a Neonatologist at Women & Infants Hospital in Providence, Rhode Island. He attended and graduated from Philadelphia College of Osteopathic Medicine in 2006, completed his pediatric residence at the Medical College of Virginia at Virginia Commonwealth University, and his neonatology training at Loma Linda Children’s Hospital in southern California. He is currently the Medical Director of the Mother Baby Unit at Women & Infants. The Mother Baby Unit is a combination unit providing newborn nursery care and care to substance exposed newborns.
Dr. Czynski current research interests are in the field of Neonatal Abstinence Syndrome. He worked as the site PI for the B.A.B.Y Trial which was a prospective clinical trial comparing morphine vs methadone for the treatment of NAS. For the COBRE he is planning to compare the effects of buprenorphine vs morphine for the treatment of NAS. Dr. Czynski is also the PI for a weaning trial comparing the rapid vs slow wean taper for the treatment of NAS that will be conducted throughout the Neonatal Research Network and the IDeA State Pediatric Clinical Trial Network. In addition to investigating pharmacologic treat of NAS he is also focusing on the long term neurodevelopmental and behavioral effects of fetal opioid exposure. Dr. Czynski in collaboration with the Rhode Island Department of Health have developed a care map for infants with fetal opioid exposure. The care map connects hospital based and community based family resources to support parenting, sobriety, and maximize infant development. Dr. Czynski and Dr. Barry Lester also established the state’s first long term developmental follow up clinic exclusively for opioid exposed newborns. Prior to Dr. Czynski’s work in NAS he work on developing NICU based disaster response plans and lead regional disaster response efforts to NICUs across southern California.